Volcano Corporation
Schedules Second Quarter Conference Call and Webcast
|
|
IVUS
cross-sectional view
of
coronary artery |
|
July 29,
2008 -- San Diego -- Volcano Corporation (Nasdaq:
VOLC), a leading manufacturer and developer of intravascular
ultrasound (IVUS),
functional measurement (FM) and Optical Coherence Tomography
(OCT) products designed to enhance the diagnosis and treatment
of coronary and peripheral vascular disease, today announced
that it will report its operating results for the second quarter
and first six months of fiscal 2008 on Tuesday, August 5.
|
The company will hold a conference call to discuss
its financial results and operating activities open to all interested
parties at 2 p.m., Pacific Daylight Time, (5 p.m., Eastern Daylight
Time), Tuesday, August 5, hosted by Scott Huennekens, president and
chief executive officer, and John Dahldorf, chief financial officer.
The teleconference can be accessed by calling (719)
325-4886, passcode 4988988. Please dial in 10-15 minutes prior to
the beginning of the
call. The webcast will be available through the company's website
at http://www.volcanocorp.com.
A replay of the conference call will be available through Monday, August 11, at (719) 457-0820, passcode 4988988, and via the company's website.
About Volcano Corporation
Volcano Corporation (NASDAQ: VOLC) offers a broad suite of devices
designed to facilitate endovascular procedures, enhance the diagnosis
of vascular and structural heart disease and guide optimal therapies.
The company's intravascular ultrasound (IVUS) product line includes
ultrasound consoles that can be integrated directly into virtually
any modern cath lab. Volcano IVUS offers unique features, including
both single-use phased array and rotational IVUS imaging catheters,
and advanced functionality options, such as VH(TM) tissue characterization
and ChromaFlo(R). Volcano also provides functional measurement (FM)
consoles and single-use pressure and flow guide wires and is developing
a line of ultra high-resolution Optical Coherent Tomography (OCT) systems
and catheters. Currently, more than 3,300 Volcano IVUS and FM systems
are installed worldwide with approximately half of its revenues coming
from outside the United States. For more information, visit the company's
website at http://www.volcanocorp.com.
Source: Volcano Corporation
|